Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Journal
Age
Showing 1 to 12 of 75 entries
Sorted by: Best Match Show Resources per page
T3 levels in anorexia nervosa.

Journal of the American Academy of Child and Adolescent Psychiatry

Berry EM, Caraco Y, Roth D.
PMID: 2005058
J Am Acad Child Adolesc Psychiatry. 1991 Jan;30(1):156-7. doi: 10.1097/00004583-199101000-00032.

No abstract available.

Cite
Berry EM, Caraco Y, Roth D. T3 levels in anorexia nervosa. J Am Acad Child Adolesc Psychiatry. 1991;30(1):156-7doi: 10.1097/00004583-199101000-00032.
Berry, E. M., Caraco, Y., & Roth, D. (1991). T3 levels in anorexia nervosa. Journal of the American Academy of Child and Adolescent Psychiatry, 30(1), 156-7. https://doi.org/10.1097/00004583-199101000-00032
Berry, E M, et al. "T3 levels in anorexia nervosa." Journal of the American Academy of Child and Adolescent Psychiatry vol. 30,1 (1991): 156-7. doi: https://doi.org/10.1097/00004583-199101000-00032
Berry EM, Caraco Y, Roth D. T3 levels in anorexia nervosa. J Am Acad Child Adolesc Psychiatry. 1991 Jan;30(1):156-7. doi: 10.1097/00004583-199101000-00032. PMID: 2005058.
Copy Download .nbib Format: NLM
Septic arthritis of the sternoclavicular joint in healthy adults.

Journal of internal medicine

Gillis S, Friedman B, Caraco Y, Blankstein A, Yellin A, Friedman G.
PMID: 2401877
J Intern Med. 1990 Sep;228(3):275-8. doi: 10.1111/j.1365-2796.1990.tb00231.x.

Septic arthritis of the sternoclavicular joint (SCJ) is a rare disorder, and is usually associated with predisposing factors such as contiguous foci of infection, heroin addiction, rheumatoid arthritis and diabetes mellitus. Three cases in previously healthy adults are reported...

Cite
Gillis S, Friedman B, Caraco Y, et al. Septic arthritis of the sternoclavicular joint in healthy adults. J Intern Med. 1990;228(3):275-8doi: 10.1111/j.1365-2796.1990.tb00231.x.
Gillis, S., Friedman, B., Caraco, Y., Blankstein, A., Yellin, A., & Friedman, G. (1990). Septic arthritis of the sternoclavicular joint in healthy adults. Journal of internal medicine, 228(3), 275-8. https://doi.org/10.1111/j.1365-2796.1990.tb00231.x
Gillis, S, et al. "Septic arthritis of the sternoclavicular joint in healthy adults." Journal of internal medicine vol. 228,3 (1990): 275-8. doi: https://doi.org/10.1111/j.1365-2796.1990.tb00231.x
Gillis S, Friedman B, Caraco Y, Blankstein A, Yellin A, Friedman G. Septic arthritis of the sternoclavicular joint in healthy adults. J Intern Med. 1990 Sep;228(3):275-8. doi: 10.1111/j.1365-2796.1990.tb00231.x. PMID: 2401877.
Copy Download .nbib Format: NLM
Does restriction of caffeine intake affect mixed function oxidase activity and caffeine metabolism?.

Biopharmaceutics & drug disposition

Caraco Y, Zylber-Katz E, Granit L, Levy M.
PMID: 1979925
Biopharm Drug Dispos. 1990 Oct;11(7):639-43. doi: 10.1002/bdd.2510110709.

No abstract available.

Cite
Caraco Y, Zylber-Katz E, Granit L, et al. Does restriction of caffeine intake affect mixed function oxidase activity and caffeine metabolism?. Biopharm Drug Dispos. 1990;11(7):639-43doi: 10.1002/bdd.2510110709.
Caraco, Y., Zylber-Katz, E., Granit, L., & Levy, M. (1990). Does restriction of caffeine intake affect mixed function oxidase activity and caffeine metabolism?. Biopharmaceutics & drug disposition, 11(7), 639-43. https://doi.org/10.1002/bdd.2510110709
Caraco, Y, et al. "Does restriction of caffeine intake affect mixed function oxidase activity and caffeine metabolism?." Biopharmaceutics & drug disposition vol. 11,7 (1990): 639-43. doi: https://doi.org/10.1002/bdd.2510110709
Caraco Y, Zylber-Katz E, Granit L, Levy M. Does restriction of caffeine intake affect mixed function oxidase activity and caffeine metabolism?. Biopharm Drug Dispos. 1990 Oct;11(7):639-43. doi: 10.1002/bdd.2510110709. PMID: 1979925.
Copy Download .nbib Format: NLM
Bethanechol-induced cholinergic toxicity in diabetic neuropathy.

DICP : the annals of pharmacotherapy

Caraco Y, Arnon R, Raz I.
PMID: 2316243
DICP. 1990 Mar;24(3):327-8. doi: 10.1177/106002809002400325.

No abstract available.

Cite
Caraco Y, Arnon R, Raz I. Bethanechol-induced cholinergic toxicity in diabetic neuropathy. DICP. 1990;24(3):327-8doi: 10.1177/106002809002400325.
Caraco, Y., Arnon, R., & Raz, I. (1990). Bethanechol-induced cholinergic toxicity in diabetic neuropathy. DICP : the annals of pharmacotherapy, 24(3), 327-8. https://doi.org/10.1177/106002809002400325
Caraco, Y, et al. "Bethanechol-induced cholinergic toxicity in diabetic neuropathy." DICP : the annals of pharmacotherapy vol. 24,3 (1990): 327-8. doi: https://doi.org/10.1177/106002809002400325
Caraco Y, Arnon R, Raz I. Bethanechol-induced cholinergic toxicity in diabetic neuropathy. DICP. 1990 Mar;24(3):327-8. doi: 10.1177/106002809002400325. PMID: 2316243.
Copy Download .nbib Format: NLM
Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone.

European journal of clinical pharmacology

Cohen O, Zylber-Katz E, Caraco Y, Granit L, Levy M.
PMID: 9832297
Eur J Clin Pharmacol. 1998 Sep;54(7):549-53. doi: 10.1007/s002280050511.

OBJECTIVE: Dipyrone is a veteran analgesic and antipyretic drug. After oral administration it is rapidly converted by hydrolysis to 4-methylaminoantipyrine (MAA), which is further metabolized to 4-formylaminoantipyrine (FAA), 4-aminoantipyrine (AA) and 4-acetylaminoantipyrine (AAA). It is still debated whether the...

Cite
Cohen O, Zylber-Katz E, Caraco Y, et al. Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone. Eur J Clin Pharmacol. 1998;54(7):549-53doi: 10.1007/s002280050511.
Cohen, O., Zylber-Katz, E., Caraco, Y., Granit, L., & Levy, M. (1998). Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone. European journal of clinical pharmacology, 54(7), 549-53. https://doi.org/10.1007/s002280050511
Cohen, O, et al. "Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone." European journal of clinical pharmacology vol. 54,7 (1998): 549-53. doi: https://doi.org/10.1007/s002280050511
Cohen O, Zylber-Katz E, Caraco Y, Granit L, Levy M. Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone. Eur J Clin Pharmacol. 1998 Sep;54(7):549-53. doi: 10.1007/s002280050511. PMID: 9832297.
Copy Download .nbib Format: NLM
Ticlopidine-induced thrombotic thrombocytopenic purpura.

Pharmacotherapy

Muszkat M, Shapira MY, Sviri S, Linton DM, Caraco Y.
PMID: 9855338
Pharmacotherapy. 1998 Nov-Dec;18(6):1352-5.

Thrombotic thrombocytopenic purpura (TTP) occurs in association with a wide variety of disorders including infections, connective tissue diseases, and solid organ tumors. It also may coincide with administration of drugs such as mitomycin, metronidazole, oral contraceptives, cyclosporine, and many...

Cite
Muszkat M, Shapira MY, Sviri S, et al. Ticlopidine-induced thrombotic thrombocytopenic purpura. Pharmacotherapy. 1998;18(6):1352-5
Muszkat, M., Shapira, M. Y., Sviri, S., Linton, D. M., & Caraco, Y. (1998). Ticlopidine-induced thrombotic thrombocytopenic purpura. Pharmacotherapy, 18(6), 1352-5.
Muszkat, M, et al. "Ticlopidine-induced thrombotic thrombocytopenic purpura." Pharmacotherapy vol. 18,6 (1998): 1352-5.
Muszkat M, Shapira MY, Sviri S, Linton DM, Caraco Y. Ticlopidine-induced thrombotic thrombocytopenic purpura. Pharmacotherapy. 1998 Nov-Dec;18(6):1352-5. PMID: 9855338.
Copy Download .nbib Format: NLM
Zuclopenthixol-associated neutropenia and thrombocytopenia.

The Annals of pharmacotherapy

Hirshberg B, Gural A, Caraco Y.
PMID: 10860136
Ann Pharmacother. 2000 Jun;34(6):740-2. doi: 10.1345/aph.18468.

OBJECTIVE: To report a case of neutropenia and thrombocytopenia secondary to use of zuclopenthixol in a schizophrenic patient.CASE SUMMARY: A 66-year-old white man with chronic schizophrenia was referred to the hospital due to neutropenia and thrombocytopenia that developed shortly...

Cite
Hirshberg B, Gural A, Caraco Y. Zuclopenthixol-associated neutropenia and thrombocytopenia. Ann Pharmacother. 2000;34(6):740-2doi: 10.1345/aph.18468.
Hirshberg, B., Gural, A., & Caraco, Y. (2000). Zuclopenthixol-associated neutropenia and thrombocytopenia. The Annals of pharmacotherapy, 34(6), 740-2. https://doi.org/10.1345/aph.18468
Hirshberg, B, et al. "Zuclopenthixol-associated neutropenia and thrombocytopenia." The Annals of pharmacotherapy vol. 34,6 (2000): 740-2. doi: https://doi.org/10.1345/aph.18468
Hirshberg B, Gural A, Caraco Y. Zuclopenthixol-associated neutropenia and thrombocytopenia. Ann Pharmacother. 2000 Jun;34(6):740-2. doi: 10.1345/aph.18468. PMID: 10860136.
Copy Download .nbib Format: NLM
Major bleeding caused by warfarin in a genetically susceptible patient.

Pharmacotherapy

Bloch A, Ben-Chetrit E, Muszkat M, Caraco Y.
PMID: 11794436
Pharmacotherapy. 2002 Jan;22(1):97-101. doi: 10.1592/phco.22.1.97.33491.

A 90-year-old woman was hospitalized for gastrointestinal bleeding. Although she had been receiving only warfarin 5 mg/day, her international normalized ratio (INR) was 66. Warfarin was discontinued, and her INR fell to 3.7 after transfusion of fresh-frozen plasma. However,...

Cite
Bloch A, Ben-Chetrit E, Muszkat M, et al. Major bleeding caused by warfarin in a genetically susceptible patient. Pharmacotherapy. 2002;22(1):97-101doi: 10.1592/phco.22.1.97.33491.
Bloch, A., Ben-Chetrit, E., Muszkat, M., & Caraco, Y. (2002). Major bleeding caused by warfarin in a genetically susceptible patient. Pharmacotherapy, 22(1), 97-101. https://doi.org/10.1592/phco.22.1.97.33491
Bloch, Aharon, et al. "Major bleeding caused by warfarin in a genetically susceptible patient." Pharmacotherapy vol. 22,1 (2002): 97-101. doi: https://doi.org/10.1592/phco.22.1.97.33491
Bloch A, Ben-Chetrit E, Muszkat M, Caraco Y. Major bleeding caused by warfarin in a genetically susceptible patient. Pharmacotherapy. 2002 Jan;22(1):97-101. doi: 10.1592/phco.22.1.97.33491. PMID: 11794436.
Copy Download .nbib Format: NLM
Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation.

Hepatology (Baltimore, Md.)

Adler R, Safadi R, Caraco Y, Rowe M, Etzioni A, Ashur Y, Shouval D.
PMID: 10094978
Hepatology. 1999 Apr;29(4):1299-305. doi: 10.1002/hep.510290446.

Hepatitis B virus (HBV) immune globulin (HBIg) administration will prevent HBV graft reinfection in HBV patients after orthotopic liver transplantation (OLT). However, the expenditure for such prophylaxis is extremely high ranging between $2,000 to $10,000 per month in various...

Cite
Adler R, Safadi R, Caraco Y, et al. Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation. Hepatology. 1999;29(4):1299-305doi: 10.1002/hep.510290446.
Adler, R., Safadi, R., Caraco, Y., Rowe, M., Etzioni, A., Ashur, Y., & Shouval, D. (1999). Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation. Hepatology (Baltimore, Md.), 29(4), 1299-305. https://doi.org/10.1002/hep.510290446
Adler, R, et al. "Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation." Hepatology (Baltimore, Md.) vol. 29,4 (1999): 1299-305. doi: https://doi.org/10.1002/hep.510290446
Adler R, Safadi R, Caraco Y, Rowe M, Etzioni A, Ashur Y, Shouval D. Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation. Hepatology. 1999 Apr;29(4):1299-305. doi: 10.1002/hep.510290446. PMID: 10094978.
Copy Download .nbib Format: NLM
Lack of mediastinal shift as a clue to delayed postpneumonectomy empyema.

Southern medical journal

Hirshberg B, Shapira MY, Grinblat I, Shustin L, Caraco Y.
PMID: 10653075
South Med J. 2000 Jan;93(1):80-2.

Delayed postpneumonectomy empyema is uncommon. The condition is usually elusive and diagnosed late in the course of the disease, leading to increased morbidity. New air-fluid level on chest x-ray film or appearance of empyema necessitatis may enhance the index...

Cite
Hirshberg B, Shapira MY, Grinblat I, et al. Lack of mediastinal shift as a clue to delayed postpneumonectomy empyema. South Med J. 2000;93(1):80-2
Hirshberg, B., Shapira, M. Y., Grinblat, I., Shustin, L., & Caraco, Y. (2000). Lack of mediastinal shift as a clue to delayed postpneumonectomy empyema. Southern medical journal, 93(1), 80-2.
Hirshberg, B, et al. "Lack of mediastinal shift as a clue to delayed postpneumonectomy empyema." Southern medical journal vol. 93,1 (2000): 80-2.
Hirshberg B, Shapira MY, Grinblat I, Shustin L, Caraco Y. Lack of mediastinal shift as a clue to delayed postpneumonectomy empyema. South Med J. 2000 Jan;93(1):80-2. PMID: 10653075.
Copy Download .nbib Format: NLM
Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population.

Clinical pharmacology and therapeutics

Sviri S, Shpizen S, Leitersdorf E, Levy M, Caraco Y.
PMID: 10096259
Clin Pharmacol Ther. 1999 Mar;65(3):275-82. doi: 10.1016/S0009-9236(99)70106-2.

OBJECTIVES: Evaluation of CYP2C19 activity and the frequency of CYP2C19 alleles in the Jewish Israeli population.METHODS: One hundred forty Jewish Israeli subjects received 100 mg racemic mephenytoin and collected urine for 8 hours. Urinary concentrations of mephenytoin enantiomers and...

Cite
Sviri S, Shpizen S, Leitersdorf E, et al. Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population. Clin Pharmacol Ther. 1999;65(3):275-82doi: 10.1016/S0009-9236(99)70106-2.
Sviri, S., Shpizen, S., Leitersdorf, E., Levy, M., & Caraco, Y. (1999). Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population. Clinical pharmacology and therapeutics, 65(3), 275-82. https://doi.org/10.1016/S0009-9236(99)70106-2
Sviri, S, et al. "Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population." Clinical pharmacology and therapeutics vol. 65,3 (1999): 275-82. doi: https://doi.org/10.1016/S0009-9236(99)70106-2
Sviri S, Shpizen S, Leitersdorf E, Levy M, Caraco Y. Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population. Clin Pharmacol Ther. 1999 Mar;65(3):275-82. doi: 10.1016/S0009-9236(99)70106-2. PMID: 10096259.
Copy Download .nbib Format: NLM
Duration of analgesia and pruritus following intrathecal fentanyl for labour analgesia: no significant effect of A118G μ-opioid receptor polymorphism, but a marked effect of ethnically distinct hospital populations.

British journal of anaesthesia

Ginosar Y, Birnbach DJ, Shirov TT, Arheart K, Caraco Y, Davidson EM.
PMID: 23592691
Br J Anaesth. 2013 Sep;111(3):433-44. doi: 10.1093/bja/aet075. Epub 2013 Apr 16.

BACKGROUND: Genetic polymorphism (A118G) in the μ-opioid receptor has been reported to affect systemic opioid analgesia. However, reported pharmacogenetic effects on spinal opioid analgesia, particularly in labour, have been equivocal.METHODS: We prospectively assessed effects of the μ-opioid receptor A118G...

Cite
Ginosar Y, Birnbach DJ, Shirov TT, et al. Duration of analgesia and pruritus following intrathecal fentanyl for labour analgesia: no significant effect of A118G μ-opioid receptor polymorphism, but a marked effect of ethnically distinct hospital populations. Br J Anaesth. 2013;111(3):433-44doi: 10.1093/bja/aet075.
Ginosar, Y., Birnbach, D. J., Shirov, T. T., Arheart, K., Caraco, Y., & Davidson, E. M. (2013). Duration of analgesia and pruritus following intrathecal fentanyl for labour analgesia: no significant effect of A118G μ-opioid receptor polymorphism, but a marked effect of ethnically distinct hospital populations. British journal of anaesthesia, 111(3), 433-44. https://doi.org/10.1093/bja/aet075
Ginosar, Y, et al. "Duration of analgesia and pruritus following intrathecal fentanyl for labour analgesia: no significant effect of A118G μ-opioid receptor polymorphism, but a marked effect of ethnically distinct hospital populations." British journal of anaesthesia vol. 111,3 (2013): 433-44. doi: https://doi.org/10.1093/bja/aet075
Ginosar Y, Birnbach DJ, Shirov TT, Arheart K, Caraco Y, Davidson EM. Duration of analgesia and pruritus following intrathecal fentanyl for labour analgesia: no significant effect of A118G μ-opioid receptor polymorphism, but a marked effect of ethnically distinct hospital populations. Br J Anaesth. 2013 Sep;111(3):433-44. doi: 10.1093/bja/aet075. Epub 2013 Apr 16. PMID: 23592691.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 75 entries